Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer
Authors:
- Rayjean J. HungRHRayjean J. Hung
- Cornelia M. UlrichCUCornelia M. Ulrich
- Ellen L. GoodeEGEllen L. Goode
- Yonathan BrhaneYBYonathan Brhane
- Kenneth MuirKMKenneth Muir
- Andrew T. ChanACAndrew T. Chan
- Loic Le MarchandLMLoic Le Marchand
- Joellen SchildkrautJSJoellen Schildkraut
- John S. WitteJWJohn S. Witte
- Rosalind EelesRERosalind Eeles
- Paolo BoffettaPBPaolo Boffetta
- Margaret R. SpitzMSMargaret R. Spitz
Open Access
- 29 August 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 107 (11)
Abstract
Inflammation has been hypothesized to increase the risk of cancer development as an initiator or promoter, yet no large-scale study of inherited variation across cancer sites has been conducted. We conducted a cross-cancer genomic analysis for the inflammation pathway based on 48 genome-wide association studies within the National Cancer Institute GAME-ON Network across five common cancer sites, with a total of 64 591 cancer patients and 74 467 control patients. Subset-based meta-analysis was used to account for possible disease heterogeneity, and hierarchical modeling was employed to estimate the effect of the subcomponents within the inflammation pathway. The network was visualized by enrichment map. All statistical tests were two-sided. We identified three pleiotropic loci within the inflammation pathway, including one novel locus in Ch12q24 encoding SH2B3 (rs3184504), which reached GWAS significance with a P value of 1.78 x 10–8, and it showed an association with lung cancer (P = 2.01 x 10–6), colorectal cancer (GECCO P = 6.72x10-6; CORECT P = 3.32x10-5), and breast cancer (P = .009). We also identified five key subpathway components with genetic variants that are relevant for the risk of these five cancer sites: inflammatory response for colorectal cancer (P = .006), inflammation related cell cycle gene for lung cancer (P = 1.35x10-6), and activation of immune response for ovarian cancer (P = .009). In addition, sequence variations in immune system development played a role in breast cancer etiology (P = .001) and innate immune response was involved in the risk of both colorectal (P = .022) and ovarian cancer (P = .003). Genetic variations in inflammation and its related subpathway components are keys to the development of lung, colorectal, ovary, and breast cancer, including SH2B3, which is associated with lung, colorectal, and breast cancer.Keywords
This publication has 90 references indexed in Scilit:
- TLR4 Activates the β-catenin Pathway to Cause Intestinal NeoplasiaPLOS ONE, 2013
- A Subset-Based Approach Improves Power and Interpretation for the Combined Analysis of Genetic Association Studies of Heterogeneous TraitsThe American Journal of Human Genetics, 2012
- Telomerase and idiopathic pulmonary fibrosisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- Telomerase regulationMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- Maintaining the end: Roles of telomere proteins in end-protection, telomere replication and length regulationMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- Epidemiologic evidence for a role of telomere dysfunction in cancer etiologyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- Telomere dysfunction and chromosome instabilityMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- Meta-analysis of new genome-wide association studies of colorectal cancer riskHuman Genetics, 2011
- Meta-Analysis of Genome-wide Association Studies with Overlapping SubjectsThe American Journal of Human Genetics, 2009
- A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for AdenocarcinomaThe American Journal of Human Genetics, 2009